Carmen Llorens-Cebria
Overview
Explore the profile of Carmen Llorens-Cebria including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martos-Guillami N, Vergara A, Llorens-Cebria C, Motto A, Martinez-Diaz I, Goncalves F, et al.
Front Pharmacol
. 2024 Oct;
15:1415879.
PMID: 39434906
Introduction: Diabetic Kidney Disease (DKD) is the main cause of end-stage renal disease in the developed world. The current treatment of the DKD with renin-angiotensin system (RAS) blockade does not...
2.
Llorens-Cebria C, Nunez-Seral N, Villena-Ortiz Y, Martinez-Diaz I, Soler M, Ferrer-Costa R, et al.
J Am Soc Mass Spectrom
. 2024 Sep;
35(10):2267-2271.
PMID: 39304183
Apolipoprotein A-I (ApoA-I), one of the most abundant proteins in plasma and the major protein component of high-density lipoprotein (HDL), is naturally found in several proteoforms; two of them are...
3.
Martin M, Llorens-Cebria C, Leon-Roman J, Perurena-Prieto J, Perez-Beltran V, Saumell S, et al.
Kidney Int Rep
. 2024 Jul;
9(7):2227-2239.
PMID: 39081726
Introduction: Atypical hemolytic uremic syndrome (aHUS) is a complement system (CS)-mediated ultrarare disease that manifests as thrombotic microangiopathy (TMA) with preferential small kidney vessels involvement. Transient CS activation is also...
4.
Consegal M, Miro-Casas E, Barba I, Ruiz-Meana M, Inserte J, Benito B, et al.
Basic Res Cardiol
. 2024 May;
119(4):673-689.
PMID: 38724619
Succinate accumulates during myocardial ischemia and is rapidly oxidized during reperfusion, leading to reactive oxygen species (ROS) production through reverse electron transfer (RET) from mitochondrial complex II to complex I,...
5.
Martinez-Diaz I, Martos N, Llorens-Cebria C, Alvarez F, Bedard P, Vergara A, et al.
Int J Mol Sci
. 2023 Feb;
24(4).
PMID: 36834836
Endothelin (ET) is found to be increased in kidney disease secondary to hyperglycaemia, hypertension, acidosis, and the presence of insulin or proinflammatory cytokines. In this context, ET, via the endothelin...
6.
Vergara A, Llorens-Cebria C, Martos N, Martinez-Diaz I, Stein F, Dominguez-Baez P, et al.
Clin Sci (Lond)
. 2022 Dec;
137(1):87-104.
PMID: 36524468
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have proven to delay diabetic kidney disease (DKD) progression on top of the standard of care with the renin-angiotensin system (RAS) blockade. The molecular mechanisms...
7.
Vergara A, Jacobs-Cacha C, Llorens-Cebria C, Ortiz A, Martinez-Diaz I, Martos N, et al.
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36361612
Treatments with sodium-glucose 2 cotransporter inhibitors (SGLT2i) or endothelin receptor antagonists (ERA) have shown cardiorenal protective effects. The present study aimed to evaluate the cardiorenal beneficial effects of the combination...
8.
Llorens-Cebria C, Molina-Van den Bosch M, Vergara A, Jacobs-Cacha C, Soler M
Biomolecules
. 2022 Jan;
12(1).
PMID: 35053290
The reduction-oxidation (redox) system consists of the coupling and coordination of various electron gradients that are generated thanks to serial reduction-oxidation enzymatic reactions. These reactions happen in every cell and...